...
机译:通过PD-1 / PD-L1抑制的全身抗肿瘤免疫通过血管靶向的原发性肿瘤的光动力学治疗增强
Urology Service Department of Surgery Memorial Sloan Kettering Cancer Center New York New York.;
Urology Service Department of Surgery Memorial Sloan Kettering Cancer Center New York New York.;
Sloan Kettering Institute for Cancer Research Memorial Sloan Kettering Cancer Center New York;
Immunology Program Sloan Kettering Institute for Cancer Research Memorial Sloan Kettering Cancer;
Melanoma and Immunotherapeutics Service Department of Medicine Memorial Sloan Kettering Cancer;
Sloan Kettering Institute for Cancer Research Memorial Sloan Kettering Cancer Center New York;
Laboratory of Comparative Pathology Memorial Sloan Kettering Cancer Center The Rockefeller;
Department of Surgery Sloan Kettering Institute for Cancer Research Memorial Sloan Kettering;
Department of Surgery Sloan Kettering Institute for Cancer Research Memorial Sloan Kettering;
Department of Plant and Environmental Sciences Weizmann Institute of Science Rehovot Israel.;
Urology Service Department of Surgery Memorial Sloan Kettering Cancer Center New York New York.;
机译:通过PD-1 / PD-L1抑制的全身抗肿瘤免疫通过血管靶向的原发性肿瘤的光动力学治疗增强
机译:通过血管靶向光动力疗法的全身性抗肿瘤保护涉及细胞和体液免疫
机译:通过血管靶向光动力疗法的全身性抗肿瘤保护涉及细胞和体液免疫
机译:通过抑制肿瘤细胞的细胞保护机制来提高光动力疗法的抗肿瘤活性
机译:血管靶向光动力疗法:原位抗肿瘤疫苗接种。
机译:顺铂改变头颈部鳞状细胞癌的抗肿瘤免疫力并与PD-1 / PD-L1抑制协同作用。
机译:原位递送具有局部放射治疗的IPSC衍生的树突状细胞,产生全身抗肿瘤免疫,并在临床前差免疫肿瘤模型中提高PD-L1阻断